CLIN I C AL
Morlote Joins Genomic Diagnostics and Bioinformatics The Division of Genomic Diagnostics and Bioinformatics welcomed a new faculty member, Diana Morlote, M.D., on July 1, as assistant professor. Dr. Morlote is a former UAB Pathology fellow in Hematopathology and Molecular Genetic Pathology who joins the faculty as assistant professor. Morlote recently completed a hematopathology fellowship in the Department of Pathology, after having completed a Molecular Genetic Pathology Fellowship, also at UAB. Before moving to Birmingham, Morlote completed residency training in Anatomic and Clinical Pathology in the Department
of Pathology at Mount Sinai Medical Center (MSMC) until 2017. She received her Bachelor of Science in biology from Florida International University (FIU) and her Doctorate in Medicine from the Herbert Wertheim College of Medicine at FIU. Morlote has received many awards including a travel grant by the Association of Clinical Scientists in 2018 and the Howard Kane Resident of the Year in 2014–2015 at MSMC. She is board certified in Molecular Genetic Pathology and hematopathology. Her research interests include the molecular characterization of hematologic neoplasms and its diagnostic and prognostic implications, and flow cytometry immunophenotyping of hematologic malignancies and detection of minimal residual disease after leukemia treatment.
A New History Book on UAB Pathology This year, Dr. C. Bruce Alexander, Professor Emeritus, UAB Pathology, published a History of Pathology at UAB covering 1945‑2008. The book, edited by Margaret Dotzler, former department staff, and published by BAM! Publishing, documents the history of the department and is a compilation of facts, figures, photos and stories from more than 60 years of our Department.
12 UAB Pathology 2020 Issue 1
Marques Joins ABPath Advisory Committee
Congratulations to MARISA MARQUES, M.D., Professor, Laboratory Medicine, who has accepted a nomination to join the American Board of Pathology (ABPath) Test Development and Advisory Committee for Blood Banking/ Transfusion Medicine beginning January 2020. The organization explains the role as: “To be appointed to a TDAC means a physician is an established subject matter expert in their subspecialty field and is current on the latest advances in the continually evolving field of pathology and patient care. TDAC committee members develop and review examination questions for statistical performance and relevance to current practice. They contribute to the validity of examinations by determining the content and distribution of items on examinations (exam blueprints). The TDACs also advise the ABPath on issues in their subspecialty area of expertise.” Since 1971, the ABPath has appointed test committees for the various areas of pathology. The committees consist of ABPath trustees, and other pathologists and physicians who are recognized experts in the various disciplines. In 2001, the role of these committees was expanded to include subject matter and advisory function for the Board. “As TDAC members, these physicians play a critical role in the development of the exams and are entrusted with maintaining the integrity of the board-certified designation. The appointment to a TDAC indicates the physician is highly regarded in the field of pathology and exemplifies the utmost standards of care,” states Rebecca L. Johnson, M.D., CEO of the American Board of Pathology. Marques is the first former UAB Medicine Pathology resident to be invited to be part of the ABPath.
